Comparison of Optical Coherence Tomography Assessments in the Comparison of Age-Related Macular Degeneration Treatments Trials

被引:28
|
作者
Folgar, Francisco A. [1 ]
Jaffe, Glenn J. [1 ]
Ying, Gui-Shuang [2 ]
Maguire, Maureen G. [2 ]
Toth, Cynthia A. [1 ]
机构
[1] Duke Univ, Dept Ophthalmol, Durham, NC USA
[2] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
TIME-DOMAIN; THICKNESS MEASUREMENTS; CATEGORICAL DATA; HIGH-SPEED; REPRODUCIBILITY; AGREEMENT; RANIBIZUMAB; BEVACIZUMAB; MORPHOLOGY; RESOLUTION;
D O I
10.1016/j.ophtha.2014.04.020
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To determine agreement between spectral-domain (SD) and time-domain (TD) optical coherence tomography (OCT) image assessments by certified readers in eyes treated for neovascular age-related macular degeneration (AMD). Design: Cross-sectional study within the Comparison of AMD Treatments Trials (CATT). Participants: During year 2 of CATT, 1213 pairs of SD OCT and TD OCT scans were compared from a subset of 384 eyes. Methods: Masked readers independently graded OCT scans for presence of intraretinal fluid (IRF), subretinal fluid (SRF), and sub-retinal pigment epithelium (RPE) fluid and performed manual measurements of retinal, SRF, and subretinal tissue complex thicknesses at the foveal center. Main Outcome Measures: Presence of fluid was evaluated with percent agreement, kappa coefficients with 95% confidence intervals (CIs), and McNemar tests. Thickness measurements were evaluated with mean difference (Delta) +/- 95% limits of agreement and intraclass correlation coefficients (ICCs) with 95% CIs. Results: Between SD OCT and TD OCT, agreement on presence of any fluid was 82% (kappa = 0.46; 95% CI, 0.40-0.52), with 5% more SD OCT scans demonstrating fluid (P < 0.001). Agreement on presence of SRF was 87% and sub-RPE fluid was 80%, with more SD OCT scans demonstrating fluid (both P < 0.001). Agreement on IRF was 73% (kappa = 0.47; 95% CI, 0.42-0.52), with 6% more TD OCT scans demonstrating fluid (P < 0.001). Between SD OCT and TD OCT, mean thickness of the retina was Delta = 5 +/- 67 mu m, SRF was Delta = 1.5 +/- 35 mu m, and subretinal tissue complex was Delta = 5 +/- 86 mu m. Thickness measurements were reproducible for retina (ICC = 0.84; 95% CI, 0.83-0.86), SRF (ICC = 0.88; 95% CI, 0.86-0.89), and subretinal tissue complex (ICC = 0.91; 95% CI, 0.89-0.92), with <= 25-mu m difference in these measurements in 71%, 94%, and 61% of paired scans, respectively. Conclusions: Agreement on fluid presence and manual thickness measurements between paired scans from each OCT modality was moderate, providing a reasonable basis to compare CATT results with future SD OCT-based trials. Fluid was detected 5% more frequently with SD OCT, which may increase frequency of fluid-based treatment. Lower-resolution and artifactual interpretation of dark areas as cystoid edema may explain the greater frequency of IRF detected with TD OCT. (C) 2014 by the American Academy of Ophthalmology
引用
收藏
页码:1956 / +
页数:12
相关论文
共 50 条
  • [41] OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF SUBRETINAL FIBROSIS IN AGE-RELATED MACULAR DEGENERATION
    Miere, Alexandra
    Semoun, Oudy
    Cohen, Salomon Yves
    El Ameen, Ala'a
    Srour, Mayer
    Jung, Camille
    Oubraham, Hassiba
    Querques, Giuseppe
    Souied, Eric H.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (11): : 2275 - 2284
  • [42] Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration
    Roisman, Luiz
    Zhang, Qinqin
    Wang, Ruikang K.
    Gregori, Giovanni
    Zhang, Anqi
    Chen, Chieh-Li
    Durbin, Mary K.
    An, Lin
    Stetson, Paul F.
    Robbins, Gillian
    Miller, Andrew
    Zheng, Fang
    Rosenfeld, Philip J.
    OPHTHALMOLOGY, 2016, 123 (06) : 1309 - 1319
  • [43] Overview of the Use of Optical Coherence Tomography Angiography in Neovascular Age-Related Macular Degeneration
    Faatz, Henrik
    Lommatzsch, Albrecht
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
  • [44] Optical coherence tomography for the diagnosis of neovascular age-related macular degeneration: a systematic review
    Castillo, M. M.
    Mowatt, G.
    Lois, N.
    Elders, A.
    Fraser, C.
    Amoaku, W.
    Burr, J. M.
    Lotery, A. J.
    Ramsay, C. R.
    Azuara-Blanco, A.
    EYE, 2014, 28 (12) : 1399 - 1406
  • [45] AI-based support for optical coherence tomography in age-related macular degeneration
    Mares, Virginia
    Nehemy, Marcio B.
    Bogunovic, Hrvoje
    Frank, Sophie
    Reiter, Gregor S.
    Schmidt-Erfurth, Ursula
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
  • [46] PREDICTING RESPONSE OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION TO BEVACIZUMAB BASED ON SPECTRALIS OPTICAL COHERENCE TOMOGRAPHY
    Segal, Ori
    Barayev, Edward
    Nemet, Arie Y.
    Mimouni, Michael
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (02): : 259 - 263
  • [47] Diurnal variation of optical coherence tomography–based macular fluid in exudative age-related macular degeneration
    Blake H. Fortes
    Aaron M. Fairbanks
    Aravindh A. Nirmalan
    David O. Hodge
    Kevin Ferenchak
    Andrew J. Barkmeier
    International Journal of Retina and Vitreous, 9
  • [48] Assessment of Differential Pharmacodynamic Effects Using Optical Coherence Tomography in Neovascular Age-Related Macular Degeneration
    Keane, Pearse A.
    Heussen, Florian M.
    Ouyang, Yanling
    Mokwa, Nils
    Walsh, Alexander C.
    Tufail, Adnan
    Sadda, Srinivas R.
    Patel, Praveen J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (03) : 1152 - 1161
  • [49] Grading of Age-Related Macular Degeneration: Comparison between Color Fundus Photography, Fluorescein Angiography, and Spectral Domain Optical Coherence Tomography
    Mokwa, Nils F.
    Ristau, Tina
    Keane, Pearse A.
    Kirchhof, Bernd
    Sadda, Srinivas R.
    Liakopoulos, Sandra
    JOURNAL OF OPHTHALMOLOGY, 2013, 2013
  • [50] Anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Comparison of Age-related Macular Degeneration Treatments Trials 5year outcomes and implication for clinical practice
    Chong, Elaine W.
    Al-Qureshi, Salmaan H.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 (04) : 333 - 335